Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Assets: 2014-2025

Historic Return on Assets for Amphastar Pharmaceuticals (AMPH) over the last 11 years, with Sep 2025 value amounting to 0.06%.

  • Amphastar Pharmaceuticals' Return on Assets fell 4.00% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year decrease of 4.00%. This contributed to the annual value of 0.10% for FY2024, which is 2.00% down from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Return on Assets of 0.06% as of Q3 2025, which was down 19.76% from 0.08% recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Return on Assets ranged from a high of 0.13% in Q2 2022 and a low of 0.00% during Q1 2021.
  • Over the past 3 years, Amphastar Pharmaceuticals' median Return on Assets value was 0.09% (recorded in 2023), while the average stood at 0.09%.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Return on Assets declined by 12bps in 2021, and later rose by 12bps in 2022.
  • Amphastar Pharmaceuticals' Return on Assets (Quarterly) stood at 0.10% in 2021, then climbed by 2bps to 0.12% in 2022, then decreased by 3bps to 0.09% in 2023, then grew by 1bps to 0.10% in 2024, then dropped by 4bps to 0.06% in 2025.
  • Its last three reported values are 0.06% in Q3 2025, 0.08% for Q2 2025, and 0.08% during Q1 2025.